8 Recommended Lab Tests for Smokers to Consider

Smoking is associated with higher risks of various health concerns, including respiratory and cardiovascular issues. Each year, smoking-related health complications impact hundreds of thousands in the United States. 

Regular lab tests can help monitor for health changes that may impact smokers and can offer insights that support proactive health choices. 

This article guides you through the essential tests smokers should consider to manage their health and reduce their risk of long-term complications.

[signup]

Essential Lab Tests for Smokers

The following labs may be useful to consider ordering for patients who smoke:

Carboxyhemoglobin Test

• Purpose: A carboxyhemoglobin test measures carbon monoxide (CO) in the blood by assessing carboxyhemoglobin levels. Smokers often have elevated levels due to CO inhalation.
• Optimal Range: Under 1.5% in non-smokers.
• Benefits of Early Testing: This test may help assess CO levels, offering insights into oxygen transport and cardiovascular wellness for smokers.

Complete Blood Count (CBC)

• Purpose: A CBC detects conditions like anemia, infections, and inflammation, which are more common in smokers due to immune system impairment.
• Benefits of Early Testing: Early identification of blood changes may provide helpful information about general health and support wellness strategies.

D-Dimer Test

• Purpose: D-timer test detects abnormal blood clotting by measuring D-dimer levels. Smoking increases the risk of clots that can lead to stroke, deep vein thrombosis (DVT) or pulmonary embolism.
• Optimal Range: Less than 500 ng/mL.
• Benefits of Early Testing: Identifying elevated D-dimer levels early may offer insights into blood health and help guide further discussion with a healthcare provider.

High-sensitivity C-reactive protein (hs-CRP)

• Purpose: The hs-CRP measures inflammation in the body, especially in blood vessels. Smokers have higher inflammation, increasing the risk of cardiovascular disease.
• Optimal Range: Less than 1.0 mg/L is considered low risk for cardiovascular disease.
• Benefits of Early Testing: Identifying high CRP levels may provide information about inflammation levels, which may help individuals make informed lifestyle choices in consultation with a healthcare provider.

Lipid Panel

• Purpose: A lipid panel measures cholesterol and triglyceride levels to assess cardiovascular health, as smoking raises the risk of heart disease.
• Optimal Range: Total cholesterol: under 200 mg/dL, LDL under 100 mg/dL, HDL above 40 mg/dL for men and 50 mg/dL for women.
• Benefits of Early Testing: A lipid panel provides information on cholesterol levels, which may be helpful for monitoring cardiovascular health. 

Liver Function Tests (LFTs)

• Purpose: Measurement of LFTs provides an assessment of liver health by measuring enzyme levels. Smoking, particularly combined with alcohol use, can impair liver function.
• Optimal Range: ALT: 7-56 U/L, AST: 10-40 U/L 
• Benefits of Early Testing: Liver function tests may provide insights that help guide lifestyle adjustments to support liver wellness.

Nicotine and Cotinine Test

• Purpose: These tests measure nicotine levels and cotinine (a nicotine byproduct) in the blood, urine, or saliva. It helps confirm smoking habits and track cessation progress.
• Optimal Range: Cotinine level below 10 ng/mL for non-smokers.
• Benefits of Early Testing: Tracking nicotine and cotinine levels can help individuals and healthcare providers monitor progress in reducing nicotine exposure.

Vitamin D Test

• Purpose: Measures vitamin D levels, which are often lower in smokers. Vitamin D supports bone health and immune function.
• Optimal Range: 30-100 ng/mL.
• Benefits of Early Testing: Early identification of Vitamin D levels may support decisions about dietary intake and lifestyle choices to promote bone and immune health.

Additional Tests for Heavy Smokers

These additional tests may be beneficial as well:

Genetic Biomarkers

Testing for certain gene variations may help provide information on how some individuals respond to smoking-related exposure. Some key biomarkers include:

• CHRNA5-A3-B4 gene cluster: Variants in this gene cluster are associated with nicotine dependence and an increased risk of lung cancer. Testing for mutations here can help identify individuals at higher risk for smoking-related cancers.
• CYP1A1 gene: This gene is involved in metabolizing toxins found in cigarette smoke. Certain mutations in the CYP1A1 gene can increase the risk of lung cancer due to the slower breakdown of harmful substances from smoking.
• TP53 gene: Known as the "guardian of the genome," TP53 mutations are common in smokers and are associated with lung cancer. Testing for TP53 abnormalities can help assess cancer risk.
• GSTP1 (Glutathione S-transferase): This enzyme detoxifies carcinogens, including those found in tobacco smoke. Smokers with specific GSTP1 polymorphisms may have a reduced ability to detoxify smoke-related carcinogens, leading to a higher risk of lung and other cancers.
• MTHFR gene: Mutations in the MTHFR gene can increase susceptibility to heart disease, especially in smokers. Testing for this gene may help reduce cardiovascular risks through tailored lifestyle changes.

Pulmonary Function Test (PFT)

• Purpose: PFTs assess lung function and help diagnose conditions like chronic obstructive pulmonary disease, emphysema, or chronic bronchitis, which are common in smokers. The test measures how well the lungs can inhale, exhale, and transfer oxygen.
• Normal Results: Normal results vary based on age, sex, and height but generally show lung function around 80% or higher of the predicted value.  PFTs contain several measurements. Among those, clinicians often reference:some text
  • FEV1%: Measures the percentage of the lung volume that can be exhaled in the first second of a forced breath.  The optimal range is generally 80% or higher of the predicted value based on age, gender, and height.
  • DLCO%: Assesses the lung's ability to transfer gas from the alveoli (air sacs) into the blood. The optimal range is 75% to 140% of the predicted value based on age, gender, and height.
• Pros: Pulmonary function tests may help assess lung health and support decisions related to respiratory wellness.
• Cons: PFTs may not detect lung issues in the early stages or mild smokers.

Chest X-Ray

• Purpose: A chest X-ray detects lung abnormalities, such as early signs of lung cancer, COPD, emphysema, or chronic bronchitis. Smokers are at increased risk for these conditions due to prolonged exposure to harmful chemicals in cigarettes.
• Normal Results: A normal chest X-ray shows clear lung fields without any abnormal masses or fluid.
• Pros: It’s a quick, non-invasive screening tool that can help identify significant lung issues.
• Cons: Chest X-rays may not detect small tumors or early-stage lung cancer, which makes them less sensitive than other imaging techniques like CT scans.

Cancer Screening - Low-Dose Computed Tomography (CT) Scan

• Purpose: Low-dose CT scans are recommended for lung cancer screening in smokers, especially those aged 50-80 with a significant smoking history (20 pack-years or more). This test can detect lung cancer earlier than a chest X-ray.
• Normal Results: No signs of abnormal masses or nodules in the lungs.
• Pros: Low-dose CT scans may help identify lung changes earlier and support healthcare provider recommendations for ongoing monitoring
• Cons: It may lead to false positives, requiring further testing. Radiation exposure is also a concern, though the dose is lower than traditional CT scans.

How Often Should Smokers Get Tested?

The frequency of tests for smokers depends on factors like age, smoking history, and current health conditions. For example, heavy smokers (20+ pack-years) should undergo a low-dose CT scan for lung cancer screening annually, typically between ages 50-80, as recommended by the U.S. Preventive Services Task Force.

Smokers may benefit from having lipid profiles checked regularly, especially if they have additional cardiovascular health considerations. Complete Blood Counts (CBC) and C-reactive Protein (CRP) tests can be done yearly to monitor inflammation and detect potential blood-related conditions.

Routine vs. Symptomatic Testing

Routine tests are preventive and occur regularly, regardless of symptoms. However, if a smoker develops symptoms like persistent cough, unexplained weight loss, or blood in sputum, more urgent diagnostic testing, such as a chest X-ray or CT scan, and PFTs may be needed. Symptomatic testing ensures any emerging health issues are caught and treated early.

Lifestyle Changes to Improve Test Results

• Quitting Smoking: Smoking cessation is the most important lifestyle change a smoker can make. It immediately reduces inflammation and improves lung function. some text
  • Quitting smoking may support lung and heart health and may help reduce inflammation over time.
  • Blood pressure and cholesterol levels tend to normalize, improving results on tests like lipid profiles and C-reactive protein (CRP) levels. 
  • Pulmonary function tests (PFTs) will show improved lung capacity, especially within months of quitting, while annual CT scans can help ensure no further lung damage is occurring.
• Diet: Adopting a healthy diet rich in fruits, vegetables, whole grains, and lean proteins can help reduce systemic inflammation and improve cardiovascular health. Antioxidant-rich foods, such as berries, leafy greens, and nuts, combat oxidative stress caused by smoking. Limiting processed foods and sodium also helps control blood pressure and improve cholesterol levels.
• Exercise:  Regular exercise is equally important. Engaging in cardiovascular activities like walking, swimming, or cycling boosts heart and lung function, improving results on pulmonary tests and reducing the risk of sequelae such as heart disease. Strength training helps maintain bone density, which is often reduced in smokers. 

How to Talk to Your Doctor About Smoking-Related Testing

Prepare for the Conversation

Before your appointment, gather information about your smoking history, such as how long you've smoked and how much per day. Be honest about any symptoms you’re experiencing, such as shortness of breath, frequent coughing, or fatigue. Write down any concerns or questions you have about your health, and make sure to mention if you’re ready to quit smoking or if you’ve already cut down.

When discussing smoking-related tests, it’s important to ask specific questions, such as:

• “How often should I get tested for lung function or cancer screening?”
• “What do my test results mean for my overall health?”
• “Are there any additional tests I should consider based on my smoking history?”
• “What steps can I take to improve my test results and lower my risk?”
• “How will quitting smoking impact my future test results and health?”

These questions can help you better understand your health risks and create a plan for testing and ongoing monitoring. 

[signup]

Key Takeaways

• Laboratory tests that may support health monitoring for smokers include carboxyhemoglobin, CBC, D-dimer, CRP, lipid profile, liver function tests, nicotine, cotinine, and vitamin D levels. 
• Specific genetic biomarkers in smokers can help assess their risk for smoking-related diseases and offer targeted prevention strategies.
• Other tests that heavy (20+ pack years) smokers should have performed are: some text
  • Pulmonary Function Tests annually
  • Chest X-ray if symptomatic 
  • Cancer Screening (Low-Dose CT Scan) annually
• Routine vs. Symptomatic Testing: Preventive testing is essential even without symptoms, but urgent testing should occur if smokers experience issues like a persistent cough or chest pain.
• Lifestyle Changes: Quitting smoking, along with a healthy diet and regular exercise, can significantly improve test results and lower long-term health risks, such as heart disease and lung cancer.